PharmaLytica Virtual Expo Connect: India’s Largest Pharmaceutical Virtual Marketplace
30 September 2020: Informa Markets in India (formerly UBM India) , organizers of CPhI / P-MEC India and PharmaLytica, the leading global pharma trade shows and conferences, is excited to present its first PharmaLytica Virtual Expo Connect from 30th September to 1st October 2020. The two-day virtual expo will bring together world’s leading pharma companies, eminent speakers, a knowledge forum and unparalleled networking opportunities, under the most advanced digital ecosystem. The expo will be marked by over 3000 leading pharma companies that cater to markets such as Pharmaceutical ingredients, Pharma machinery and packaging, laboratory services and analytical services.
This digital event will be a part of the Informa Markets in India’s Super September- Virtual B2B celebration, a powerful array of 6 digital expos in 6 key verticals in the month of September 2020. The initiative of the Virtual B2B Celebrations will help the relevant communities, and businesses overcome the limitations of lockdown, achieve business goals and provide a powerful edge as the economy readies itself to get back on track.
The global threat currently posed by COVID-19 and the subsequent stringent safety measures including travel restrictions, has impacted the exhibitions industry. PharmaLytica Virtual Expo Connect is crafted to consistently meet the needs of the Pharma sector and enable professionals to sustain their critical business conversations and engagement and provide them with feasible solutions at a time when physical transactions are on a hold.
Supported by Pharmexcil (Pharmaceuticals Export Promotion Council of India ), the PharmaLytica Virtual Expo Connect will include the following companies -MPA Technical Devices, Thermo Fisher Scientific, Agilent Technologies India Pvt. Ltd., Shimadzu Analytical (India) Pvt Ltd, Pactech Machinery LLP, Adelbert Vegyszerek, Nicomac CleanRooms Far East LLP, Sun Teknovation Pvt. Ltd. to name a few. The e-event has also garnered interest from a formidable number of professionals, with pre-registrations from 51 countries. The event is characterized by engaging features such as an e-conference with thought leadership forums
With the Covid-19 situation creating an obstruction to economic activities, the Indian pharmaceutical industry is bracing itself for a reduction in profit margins in the short term, given the expected rise in the prices of active pharmaceutical ingredients (API) and key starting materials (KSM). Aiming to reduce import dependency and to attain self-reliance and drug security, the Indian government’s recent approval of US$ 1.3 billion healthcare package to boost the domestic manufacturing of the active pharmaceutical ingredients (API) has been a turn-around strategy for the industry.
To register click on the following link …. https://bit.ly/3061bnB